New York City, NY -- (SBWIRE) -- 10/10/2013 -- StockMarketIntel.com issues a special report on the following stocks: Titan Pharmaceuticals, Inc. (OTCBB:TTNP), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Ford Motor Company (NYSE:F), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) declined -15.76%, trading on 2.78 million shares, to end the trade at $0.909. The stock changed hands in a range of $0.80 to $1.07, bringing its market capitalization to about $75.03 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.32 and was moved to the maximum level of $2.53. Titan Pharmaceuticals, Inc. is a biopharmaceutical company developing proprietary therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of the following products: Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders; and Spheramine for the treatment of advanced Parkinson’s disease.
Will TTNP Get Buyers Even After The Recent Rally? Find Out Here
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) declined -14.76%, to complete the trading session at $19.86, with a total volume of 10.09 million shares. The stock, on average, trades on a volume of 2.33 million shares. It floated in a range of $19.65 to $23.81 during the last trading session, with a beta value of 2.76. Its market capitalization now moved to about $1.76 billion. In the past 52 weeks, the share price has not declined below $1.80 and above $29.73. ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The Company has four product candidates in clinical development led by pimavanserin, which is in Phase III development as a first-in-class treatment for Parkinson's disease psychosis.
Will ACAD Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Ford Motor Company (NYSE:F) added 0.73% and was in a range of $16.35-$16.74 before closing at $16.62. The stock completed the day with a total volume of 50.84 million shares, versus an average volume of 38.32 million shares. The share price hit its 52-week low of $9.95 and $17.77 was the best price. Ford Motor Company (Ford) operates in the global automotive industry. Ford operates in two sectors: Automotive and Financial Services. The Company manufactures or distributes automobiles across six continents. Its automotive brands include Ford and Lincoln.
For How Long Ford Motor Company will fight for Profitability? Read This Trend Analysis report
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) declined -11.13% yesterday, bringing its market capitalization around $235.32 million. The share price, after opening at $2.74, made a high of 2.74 and hovered above $2.40 to end the day at $2.43. The total number of shares that changed hands during the session was 6.08 million shares, as compared to average trading volume of 3.44 million shares. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections.
Is it the Right to Grab ACHN after the Recent Slump? Get Free Trend Analysis Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)